HD6: a novel monoclonal antibody that recognises a subset of HLA-B27 molecules strongly implicated in spondyloarthritis disease pathogenesis

HD6: a novel monoclonal antibody that recognises a subset of HLA-B27 molecules strongly implicated in spondyloarthritis disease pathogenesis

Show other versions (1)

Bibliographic Details
Main Authors:	McHugh, K, Shaw, J, Kollnberger, S, Utriainen, L, Firmin, D, Milling, S, Renner, C, Bowness, P
Format:	Conference item
Published:	2011

Similar Items

HD6: A NOVEL MONOCLONAL ANTIBODY THAT RECOGNISES A SUBSET OF HLA-B27 MOLECULES STRONGLY IMPLICATED IN SPONDYLOARTHRITIS DISEASE PATHOGENESIS
by: McHugh, K, et al.
Published: (2011)

THE DETECTION OF A POTENTIALLY PATHOGENIC SUBSET OF HLA-B27 CONFORMERS AT THE CELL SURFACE IN A RAT MODEL OF SPA
by: Mchugh, K, et al.
Published: (2012)

HLA-B27 HEAVY CHAIN DIMER EXPRESSION IN SPONDYLOARTHRITIS
by: Rysnik, O, et al.
Published: (2012)

THE ROLE OF HLA-B27 KIR3DL2 INTERACTIONS IN THE PATHOGENESIS OF SPONDYLOARTHRITIS
by: Kollnberger, S, et al.
Published: (2012)

The role of HLA-B27 in the pathogenesis of spondyloarthritis
by: McHugh, K
Published: (2011)

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
by: McHugh, K, et al.
Published: (2014)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
by: Wong-Baeza, I, et al.
Published: (2011)

The role of HLA-B27 interactions with natural killer receptors in the pathogenesis of spondyloarthritis
by: Kollnberger, S, et al.
Published: (2007)

EXPRESSION OF HLA-B27 HEAVY CHAIN FORMS IN ANKYLOSING SPONDYLITIS AND HLA-B27 POSITIVE CELL LINES
by: Rysnik, O, et al.
Published: (2012)

The pathogenesis of spondyloarthritides - HLA-B-27 homodimer expression on human monocyte/macrophage cell lines
by: McHugh, K, et al.
Published: (2008)

Molecular Characterisation Of The Killer Cell Immunoglobulin-Like Receptor 3DL2 Binding To Aberrant HLA-B27 Heavy Chains In Spondyloarthritis
by: Hatano, H, et al.
Published: (2013)

Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue
by: Rysnik, O, et al.
Published: (2016)

HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers
by: Giles, J, et al.
Published: (2010)

The role of cell surface HLA-B27 heavy chain homodimer interactions with NK receptors in the pathogenesis of spondyloarthritis
by: Kollnberger, S
Published: (2005)

HLA-B-27 heavy chain homodimer formation and natural killer cell family interaction - comparison of two HLA-B-27 subtypes in vitro
by: Giles, J, et al.
Published: (2008)

The role of HLA-B27 in spondyloarthritis.
by: Allen, R, et al.
Published: (1999)

Direct visualisation of HLA-B27 forms in cell lines and Spondyloarthropathy tissues
by: Rysnik, O, et al.
Published: (2013)

Factors determining the cell surface expression of a novel HLA-B27 epitope
by: McHugh, K, et al.
Published: (2010)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
by: Bowness, P, et al.
Published: (2010)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
by: Bowness, P, et al.
Published: (2010)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
by: Ridley, A, et al.
Published: (2013)

The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis.
by: Kollnberger, S, et al.
Published: (2009)

HLA-B27: natural function and pathogenic role in spondyloarthritis.
by: McMichael, A, et al.
Published: (2002)

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
by: Kollnberger, S, et al.
Published: (2004)

THE ARTHRITIS-ASSOCIATED HLA-B(star)27:05 FORMS MORE CELL SURFACE B27 DIMER AND FREE HEAVY CHAIN LIGANDS FOR KIR3DL2 AND LILRB2 IMMUNORECEPTORS THAN HLA(star)B27:09
by: Shaw, J, et al.
Published: (2013)

Supplementary figures for "Inhibiting HLA-B27 homdimer-driven immune cell inflammation in Spondyloarthritis"
by: Bowness, P
Published: (2012)

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats.
by: Osiris Marroquin Belaunzaran, et al.
Published: (2015-01-01)

HLA-B*2709, A SUBTYPE NOT ASSOCIATED WITH ANKYLOSING SPONDYLITIS, FORMS FEWER HOMODIMERS THAN HLA-B*2705
by: Giles, J, et al.
Published: (2010)

The link between HLA-B27 and SpA--new ideas on an old problem.
by: McHugh, K, et al.
Published: (2012)

HLA-B27 FORMS HEAVY CHAIN HOMODIMERS IN VITRO AND IN VIVO THAT BIND TO CELLULAR RECEPTORS INCLUDING LILR AND KIR FAMILY MEMBERS
by: McHugh, K, et al.
Published: (2010)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
by: Kollnberger, S, et al.
Published: (2010)

Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.
by: Payeli, S, et al.
Published: (2012)

Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis
by: Ridley, A, et al.
Published: (2016)

DIRECT VISUALIZATION OF HLA-B27 FORMS IN CELL LINES AND SPONDYLOARTHROPATHY TISSUES
by: Rysnik, O, et al.
Published: (2013)

Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
by: Hatano, H, et al.
Published: (2013)

Functional characterisation of HLA-B27 in autoimmunity
by: Kollnberger, S, et al.
Published: (2001)

HLA-B27 transgenic rodents express cell surface HLA-B27 heavy chain homodimers and multimers.
by: Bowness, P, et al.
Published: (2003)

Natural killer cell and synovial fibroblast cross talk - A role in the pathogenesis of spondyloarthritis
by: Chan, A, et al.
Published: (2006)

HLA-B27
by: Bowness, P
Published: (2015)

EPITOPE MAPPING OF A NOVEL B27-SPECIFIC ANTIBODY
by: Giles, J, et al.
Published: (2011)